Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study

OBJECTIVE: To report long-term health outcomes and mortality after oophorectomy or ovarian conservation. METHODS: We conducted a prospective, observational study of 29,380 women participants of the Nurses’ Health Study who had a hysterectomy for benign disease; 16,345 (55.6%) had hysterectomy with bilateral oophorectomy, and 13,035 (44.4%) had hysterectomy with ovarian conservation. We evaluated incident events or death due to coronary heart disease (CHD), stroke, breast cancer, ovarian cancer, lung cancer, colorectal cancer, total cancers, hip fracture, pulmonary embolus, and death from all causes. RESULTS: Over 24 years of follow-up, for women with hysterectomy and bilateral oophorectomy compared with ovarian conservation, the multivariable hazard ratios (HRs) were 1.12 (95% confidence interval [CI] 1.03–1.21) for total mortality, 1.17 (95% CI 1.02–1.35) for fatal plus nonfatal CHD, and 1.14 (95% CI 0.98–1.33) for stroke. Although the risks of breast (HR 0.75, 95% CI 0.68–0.84), ovarian (HR 0.04, 95% CI 0.01–0.09, number needed to treat=220), and total cancers (HR 0.90, 95% CI 0.84–0.96) decreased after oophorectomy, lung cancer incidence (HR=1.26, 95% CI 1.02–1.56, number needed to harm=190), and total cancer mortality (HR=1.17, 95% CI 1.04–1.32) increased. For those never having used estrogen therapy, bilateral oophorectomy before age 50 years was associated with an increased risk of all-cause mortality, CHD, and stroke. With an approximate 35-year life span after surgery, one additional death would be expected for every nine oophorectomies performed. CONCLUSION: Compared with ovarian conservation, bilateral oophorectomy at the time of hysterectomy for benign disease is associated with a decreased risk of breast and ovarian cancer but an increased risk of all-cause mortality, fatal and nonfatal coronary heart disease, and lung cancer. In no analysis or age group was oophorectomy associated with increased survival. LEVEL OF EVIDENCE: II

[1]  C. Schairer,et al.  Risk of myocardial infarction after oophorectomy and hysterectomy. , 2000, Journal of clinical epidemiology.

[2]  R. Berkowitz,et al.  Presence of Talc in Pelvic Lymph Nodes of a Woman With Ovarian Cancer and Long-Term Genital Exposure to Cosmetic Talc , 2007, Obstetrics and gynecology.

[3]  E. Steyerberg,et al.  Age at menopause as a risk factor for cardiovascular mortality , 1995, The Lancet.

[4]  W. Willett,et al.  Test of the National Death Index. , 1984, American journal of epidemiology.

[5]  L. Brinton,et al.  Breast cancer risk associated with gynecologic surgery and indications for such surgery , 1997, International journal of cancer.

[6]  A. Verbeek,et al.  Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. , 2002, American journal of epidemiology.

[7]  B. Weber,et al.  Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Broder,et al.  Ovarian Conservation at the Time of Hysterectomy for Benign Disease , 2005, Obstetrics and gynecology.

[9]  A. Verbeek,et al.  Age at Menopause, Cause-Specific Mortality and Total Life Expectancy , 2005, Epidemiology.

[10]  W. Willett,et al.  Tubal Ligation, Hysterectomy, and Risk of Ovarian Cancer: A Prospective Study , 1993 .

[11]  Jiaquan Xu,et al.  Deaths: final data for 2005. , 2008, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[12]  T. Evans,et al.  Medication adherence trends with statins , 2005, Advances in therapy.

[13]  W. Mack,et al.  Atherosclerosis imaging methods: assessing cardiovascular disease and evaluating the role of estrogen in the prevention of atherosclerosis. , 2002, The American journal of cardiology.

[14]  J. Manson,et al.  The Nurses' Health Study: 20-year contribution to the understanding of health among women. , 1997, Journal of women's health.

[15]  A. Whittemore,et al.  Menopause and the risk of coronary heart disease in women. , 1987, The New England journal of medicine.

[16]  J. Kelsey,et al.  Menopausal hormone therapy in a health maintenance organization before and after women's health initiative hormone trials termination. , 2006, Journal of women's health.

[17]  B. Tomlinson,et al.  Acute effects of a surgical menopause on serum concentrations of lipoprotein(a). , 1998, Climacteric : the journal of the International Menopause Society.

[18]  Acog.  ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy. , 2008, Obstetrics and gynecology.

[19]  C. Wahlberg.  Tubal ligation, hysterectomy, and risk of ovarian cancer. , 1994, JAMA.

[20]  F. Stanczyk,et al.  Ovarian androgen production in postmenopausal women. , 2007, The Journal of clinical endocrinology and metabolism.

[21]  W. Willett,et al.  Reproducibility and validity of self-reported menopausal status in a prospective cohort study. , 1987, American journal of epidemiology.

[22]  Mariza de Andrade,et al.  Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. , 2006, The Lancet. Oncology.

[23]  R. Berkowitz,et al.  Conditions Associated with Antibodies Against the Tumor-Associated Antigen MUC1 and Their Relationship to Risk for Ovarian Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[24]  D. Grobbee,et al.  Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis , 2006, Menopause.

[25]  N. Keiding,et al.  The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy. , 2006, Maturitas.

[26]  S. Yen,et al.  Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. , 1974, The Journal of clinical endocrinology and metabolism.

[27]  S. Yen,et al.  Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. , 1974, American journal of obstetrics and gynecology.